寡分割照射
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial. Tree AC, Hinder V, Chan …
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.van As N, Griffin C, Tree A, et al. N Engl J Med. 2024 Oct 17;391(15):1413-1425. DOI: 10.1056/NEJMoa2403365. PMID: 39413377; PMCID: PMC7616714. 【背景】・前立腺が…
Hypofractionated Dose Escalation versus Conventionally Fractionated Radiotherapy for Patients with Intermediate- and High-risk Localized Prostate Cancer: Long-term Results of the HYPRO trial.Wiersma RG, de Vries KC, Heemsbergen WD, et al. …
![はてなブックマーク - 【HYPRO：第III相試験 10年成績】限局性前立腺がんに対する寡分割照射（64.6 Gy/19回 [週3回]） vs. 通常分割照射（78 Gy/39回）](https://b.hatena.ne.jp/entry/image/https://uminoshion.hatenablog.com/entry/2025/10/19/104733)
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study.Ferdinandus S, Rühle A, Lamrani A, et al. J Immunother Cancer. 2025 Oct 2;…
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.Murray Brunt A, Haviland JS, Wheatley DA,e…
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.van As N, Griffin C, Tree A, et al. N Engl J Med. 2024 Oct 17;391(15):1413-1425. doi: 10.1056/NEJMoa2403365. PMID: 39413377; PMCID: PMC7616714. 【概要】・低リスク…
Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial.Niazi T, Nabid A, Malagon T, et al. Eur Urol. 2025 Mar;87(3):314-323. do…
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.Wu CHD, Wierzbicki M, Parpia S, et al. Radiother Oncol. 2025 Jan;202:110605. doi: 10.1016/…
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.Swaminath A, Parpia S, Wierzbicki M, et al. JAMA Oncol. 2024 Nov;10(11):1571-1575. doi: 10.1001/j…
Comparison of hypofractionation and conventional fractionation in postmastectomy radiotherapy after immediate breast reconstruction: A systematic review and meta-analysis of complications.Hayashi T, Ogita M, Kakegawa R, et al. Eur J Cancer…
Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized Trial. Langé M, Campion L, Ollivier L, et al. Int J Radiat Oncol Biol Phys. 2025 Jun 1;122(2):399-406. DOI: 10.1016/j.ijrobp.2025…
